Barclays’s iPath Return on Disability ETN RODI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,500
| Closed | -$1.71M | – | 5642 |
|
|
2022
Q3 | $1.71M | Hold |
16,500
| – | – | ﹤0.01% | 1856 |
|
|
2022
Q2 | $1.9M | Hold |
16,500
| – | – | ﹤0.01% | 1886 |
|
|
2022
Q1 | $1.9M | Hold |
16,500
| – | – | ﹤0.01% | 1896 |
|
|
2021
Q4 | $2.12M | Hold |
16,500
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q3 | $1.99M | Hold |
16,500
| – | – | ﹤0.01% | 2364 |
|
|
2021
Q2 | $2M | Hold |
16,500
| – | – | ﹤0.01% | 2191 |
|
|
2021
Q1 | $1.82M | Hold |
16,500
| – | – | ﹤0.01% | 2363 |
|
|
2020
Q4 | $1.6M | Hold |
16,500
| – | – | ﹤0.01% | 2424 |
|
|
2020
Q3 | $1.36M | Hold |
16,500
| – | – | ﹤0.01% | 2427 |
|
|
2020
Q2 | $1.29M | Hold |
16,500
| – | – | ﹤0.01% | 2529 |
|
|
2020
Q1 | $1.08M | Buy |
16,500
+4,500
| +38% | +$367K | ﹤0.01% | 2877 |
|
|
2019
Q4 | $1.06M | Sell |
12,000
-488,000
| -98% | -$41.5M | ﹤0.01% | 3621 |
|
|
2019
Q3 | $43.4M | Hold |
500,000
| – | – | 0.03% | 517 |
|
|
2019
Q2 | $40.4M | Hold |
500,000
| – | – | 0.02% | 562 |
|
|
2019
Q1 | $29.2M | Hold |
500,000
| – | – | 0.02% | 665 |
|
|
2018
Q4 | $25.9M | Hold |
500,000
| – | – | 0.02% | 634 |
|
|
2018
Q3 | $30.3M | Hold |
500,000
| – | – | 0.02% | 644 |
|
|
2018
Q2 | $28.2M | Buy |
+500,000
| New | +$28.2M | 0.02% | 615 |
|
|
2017
Q4 | – | Sell |
-500,000
| Closed | -$33.2M | – | 7380 |
|
|
2017
Q3 | $33.2M | Hold |
500,000
| – | – | 0.03% | 454 |
|
|
2017
Q2 | $31.9M | Hold |
500,000
| – | – | 0.03% | 416 |
|
|
2017
Q1 | $31.1M | Hold |
500,000
| – | – | 0.03% | 389 |
|
|
2016
Q4 | $29M | Hold |
500,000
| – | – | 0.03% | 438 |
|
|
2016
Q3 | $27.1M | Hold |
500,000
| – | – | 0.03% | 429 |
|
|
2016
Q2 | $25.6M | Hold |
500,000
| – | – | 0.03% | 419 |
|
|
2016
Q1 | $25.5M | Sell |
500,000
-100
| -0% | -$4.94K | 0.04% | 404 |
|
|
2015
Q4 | $25.5M | Hold |
500,100
| – | – | 0.03% | 489 |
|
|
2015
Q3 | $24M | Buy |
+500,100
| New | +$37.1M | 0.03% | 518 |
|
|
2015
Q2 | – | Sell |
-500,100
| Closed | -$18M | – | 7512 |
|
|
2015
Q1 | $18M | Buy |
500,100
+500,000
| +500,000% | +$25.4M | 0.02% | 738 |
|
|
2014
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 7051 |
|
|
2014
Q3 | $5K | Buy |
+100
| New | +$5.05K | ﹤0.01% | 7220 |
|
Barclays's RODI Position: Q4 2022 in Review
Barclays sold out of iPath Return on Disability ETN (RODI) in Q4 2022, closing a stake of 16,500 shares — an estimated $1.71M sold.
Barclays first reported a position in RODI in Q3 2014 and held it in 30 quarters. The position peaked at $43.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold RODI as of Q4 2022.
- Barclays reported no remaining iPath Return on Disability ETN position as of Q4 2022 after selling out during the quarter.
- Barclays sold 16,500 iPath Return on Disability ETN shares in Q4 2022, an estimated $1.71M.
- Barclays first reported a position in iPath Return on Disability ETN in Q3 2014 and held it in 30 quarters.
- Barclays's iPath Return on Disability ETN position peaked at $43.4M in Q3 2019.
- 0 funds tracked by Wall St. Rank held iPath Return on Disability ETN as of Q4 2022.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.